View more in
Industry

Novavax vaccine over 90% effective in protecting against COVID-19 infection, study shows

beaconjournal.com
 2021-06-14

Cover picture for the articleNovavax, the fifth company to receive major federal support for its COVID-19 vaccine, is as good as its competitors, according to data the company released Monday. The vaccine is more than 90% effective in protecting against infection and even more protective against some of the variants, according to the trial of 29,960 volunteers in the U.S. and Mexico. No one who received the active vaccine fell seriously ill.

www.beaconjournal.com

Comments / 0

Comments / 0